Recombinant Human NPFFR1 Protein，His & GST

The Neuropeptide FF receptor 1 (NPFFR1) is a G protein-coupled receptor (GPCR) that plays a crucial role in modulating pain perception and neuroendocrine functions. The receptor is activated by neuropeptides, primarily neuropeptide FF and its analogs, which are involved in a variety of physiological processes, including nociception, opioid modulation, and reproductive functions. Research into NPFFR1 has gained traction due to its potential implications in pain management and the treatment of various neuropsychiatric disorders. Moreover, NPFFR1 is of interest because it may serve as a novel target for drug development, particularly in the context of chronic pain syndromes where traditional analgesics often fail. Notably, recombinant protein studies of NPFFR1 facilitate the understanding of its structure-function relationship and signaling pathways, aiding in the identification of small molecules or peptides that can selectively modulate its activity. This research is particularly relevant in the context of advancing therapeutic strategies that target GPCRs, which are among the most significant categories of drug targets in modern pharmacology. As such, detailed characterization of NPFFR1 through recombinant techniques can provide insight into its biological roles and therapeutic potential, paving the way for innovative treatment approaches in pain and neuropsychiatric disorders.